- Home
- JELD vs SVRA Comparison
JELD vs SVRA Comparison
Compare JELD & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JELD
- SVRA
- Stock Information
- Founded
- JELD 1960
- SVRA 2007
- Country
- JELD United States
- SVRA United States
- Employees
- JELD N/A
- SVRA N/A
- Industry
- JELD Forest Products
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- JELD Basic Materials
- SVRA Health Care
- Exchange
- JELD Nasdaq
- SVRA Nasdaq
- Market Cap
- JELD 540.5M
- SVRA 505.8M
- IPO Year
- JELD 2017
- SVRA N/A
- Fundamental
- Price
- JELD $3.95
- SVRA $3.22
- Analyst Decision
- JELD Hold
- SVRA Buy
- Analyst Count
- JELD 8
- SVRA 6
- Target Price
- JELD $7.34
- SVRA $8.83
- AVG Volume (30 Days)
- JELD 2.6M
- SVRA 616.7K
- Earning Date
- JELD 05-05-2025
- SVRA 05-16-2025
- Dividend Yield
- JELD N/A
- SVRA N/A
- EPS Growth
- JELD N/A
- SVRA N/A
- EPS
- JELD N/A
- SVRA N/A
- Revenue
- JELD $3,592,492,000.00
- SVRA N/A
- Revenue This Year
- JELD N/A
- SVRA N/A
- Revenue Next Year
- JELD $4.00
- SVRA N/A
- P/E Ratio
- JELD N/A
- SVRA N/A
- Revenue Growth
- JELD N/A
- SVRA N/A
- 52 Week Low
- JELD $4.91
- SVRA $2.26
- 52 Week High
- JELD $21.75
- SVRA $5.31
- Technical
- Relative Strength Index (RSI)
- JELD 24.89
- SVRA 56.12
- Support Level
- JELD $5.31
- SVRA $3.12
- Resistance Level
- JELD $5.89
- SVRA $3.56
- Average True Range (ATR)
- JELD 0.30
- SVRA 0.18
- MACD
- JELD -0.11
- SVRA -0.02
- Stochastic Oscillator
- JELD 0.00
- SVRA 55.11
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.